Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Methylene Blue (AC161)
Cat.#: ASSD-161
Specifications
Description Methylene Blue is a redox indicator, biological dye, and soluble guanylyl cyclase inhibitor. The compound also shows antimalarial, antioxidant, and neuroprotective action. Size 50 mg, 1 g Chemical Name [7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium chloride Molecule Weight 373.9 Molecular formula C16H18ClN3S CAS Number 7220-79-3 PubChem identifier 104827 MDL Number MFCD00150006 Purity >80% Solubility Soluble in water (50mg/ml), and in ethanol (70mg/ml) Form Green solid Storage RT Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-225 Antifade Fluorescence Mounting Medium with Propidium Iodide (aqueous) (AC225) 10 mL inquiry ASSD-103 DAPI Staining Solution (1mg/mL) (AC103) 1 mL, 5 mL, inquiry ASSD-220 Nitrofluorescein, Isomer 2 (AC220) 1 g inquiry ASSD-178 5-(Iodoacetamido)fluorescein (AC178) 25 mg, 100 mg, 250 mg inquiry ASSD-191 Fluorescein 6-Isothiocyanate, Isomer 2, 95% (AC191) 100 mg inquiry ASSD-144 Oxazole Yellow Iodide (AC144) 1 mg inquiry ASSD-150 Luminol (AC150) 1 g inquiry ASSD-123 Fluorescent β2 antagonist [(S)-propranolol-red] (AC123) 500 μg inquiry ASSD-179 8-Azidoadenosine-5′-diphosphate Sodium Salt (AC179) 1 mg, 5 mg inquiry ASSD-181 Nitrofluorescein, Isomer 1 (AC181) 1 g inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket